NeuroPace Inc. Files 8-K on Security Holder Votes
Ticker: NPCE · Form: 8-K · Filed: Jun 10, 2024 · CIK: 1528287
| Field | Detail |
|---|---|
| Company | Neuropace Inc (NPCE) |
| Form Type | 8-K |
| Filed Date | Jun 10, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, sec-filing
TL;DR
NeuroPace filed an 8-K on June 10th about shareholder votes. Check it out.
AI Summary
NeuroPace Inc. filed an 8-K on June 10, 2024, reporting on matters submitted to a vote of security holders as of June 7, 2024. The filing details the company's principal executive offices located at 455 N. Bernardo Avenue, Mountain View, CA 94043, and its telephone number is (650) 237-2700. This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This filing indicates important corporate actions or decisions requiring shareholder approval, which could impact the company's governance and future direction.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate actions and does not inherently present new financial or operational risks.
Key Players & Entities
- NeuroPace Inc. (company) — Registrant
- June 7, 2024 (date) — Date of earliest event reported
- June 10, 2024 (date) — Date of Report
- 455 N. Bernardo Avenue, Mountain View, CA 94043 (address) — Principal executive offices
- (650) 237-2700 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for NeuroPace Inc.?
The primary purpose is to report on matters submitted to a vote of security holders, as of June 7, 2024.
When was this 8-K report filed with the SEC?
The report was filed on June 10, 2024.
Where are NeuroPace Inc.'s principal executive offices located?
The principal executive offices are located at 455 N. Bernardo Avenue, Mountain View, CA 94043.
What is the telephone number for NeuroPace Inc.?
The telephone number is (650) 237-2700.
Under which sections of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 560 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-06-10 17:30:00
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share NPCE Nasdaq Glo
Filing Documents
- d712440d8k.htm (8-K) — 27KB
- 0001193125-24-158459.txt ( ) — 147KB
- npce-20240607.xsd (EX-101.SCH) — 3KB
- npce-20240607_lab.xml (EX-101.LAB) — 18KB
- npce-20240607_pre.xml (EX-101.PRE) — 11KB
- d712440d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NeuroPace, Inc. Dated: June 10, 2024 By: /s/ Rebecca Kuhn Rebecca Kuhn Chief Financial Officer, Vice President, Finance and Administration, and Corporate Secretary